These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 32240984

  • 1. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: GPR101, an orphan GPCR with roles in growth and pituitary tumorigenesis.
    Trivellin G, Faucz FR, Daly AF, Beckers A, Stratakis CA.
    Endocr Relat Cancer; 2020 Aug; 27(8):T87-T97. PubMed ID: 32240984
    [Abstract] [Full Text] [Related]

  • 2. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study.
    Iacovazzo D, Caswell R, Bunce B, Jose S, Yuan B, Hernández-Ramírez LC, Kapur S, Caimari F, Evanson J, Ferraù F, Dang MN, Gabrovska P, Larkin SJ, Ansorge O, Rodd C, Vance ML, Ramírez-Renteria C, Mercado M, Goldstone AP, Buchfelder M, Burren CP, Gurlek A, Dutta P, Choong CS, Cheetham T, Trivellin G, Stratakis CA, Lopes MB, Grossman AB, Trouillas J, Lupski JR, Ellard S, Sampson JR, Roncaroli F, Korbonits M.
    Acta Neuropathol Commun; 2016 Jun 01; 4(1):56. PubMed ID: 27245663
    [Abstract] [Full Text] [Related]

  • 3. An orphan G-protein-coupled receptor causes human gigantism and/or acromegaly: Molecular biology and clinical correlations.
    Trivellin G, Hernández-Ramírez LC, Swan J, Stratakis CA.
    Best Pract Res Clin Endocrinol Metab; 2018 Apr 01; 32(2):125-140. PubMed ID: 29678281
    [Abstract] [Full Text] [Related]

  • 4. HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: The roles of AIP and GPR101 in familial isolated pituitary adenomas (FIPA).
    Vasilev V, Daly AF, Trivellin G, Stratakis CA, Zacharieva S, Beckers A.
    Endocr Relat Cancer; 2020 Aug 01; 27(8):T77-T86. PubMed ID: 32083999
    [Abstract] [Full Text] [Related]

  • 5. Gigantism: X-linked acrogigantism and GPR101 mutations.
    Iacovazzo D, Korbonits M.
    Growth Horm IGF Res; 2016 Aug 01; 30-31():64-69. PubMed ID: 27743704
    [Abstract] [Full Text] [Related]

  • 6. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism.
    Franke M, Daly AF, Palmeira L, Tirosh A, Stigliano A, Trifan E, Faucz FR, Abboud D, Petrossians P, Tena JJ, Vitali E, Lania AG, Gómez-Skarmeta JL, Beckers A, Stratakis CA, Trivellin G.
    Am J Hum Genet; 2022 Apr 07; 109(4):553-570. PubMed ID: 35202564
    [Abstract] [Full Text] [Related]

  • 7. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation.
    Trivellin G, Daly AF, Faucz FR, Yuan B, Rostomyan L, Larco DO, Schernthaner-Reiter MH, Szarek E, Leal LF, Caberg JH, Castermans E, Villa C, Dimopoulos A, Chittiboina P, Xekouki P, Shah N, Metzger D, Lysy PA, Ferrante E, Strebkova N, Mazerkina N, Zatelli MC, Lodish M, Horvath A, de Alexandre RB, Manning AD, Levy I, Keil MF, Sierra Mde L, Palmeira L, Coppieters W, Georges M, Naves LA, Jamar M, Bours V, Wu TJ, Choong CS, Bertherat J, Chanson P, Kamenický P, Farrell WE, Barlier A, Quezado M, Bjelobaba I, Stojilkovic SS, Wess J, Costanzi S, Liu P, Lupski JR, Beckers A, Stratakis CA.
    N Engl J Med; 2014 Dec 18; 371(25):2363-74. PubMed ID: 25470569
    [Abstract] [Full Text] [Related]

  • 8. The Genetic Pathophysiology and Clinical Management of the TADopathy, X-Linked Acrogigantism.
    Daly AF, Beckers A.
    Endocr Rev; 2024 Sep 12; 45(5):737-754. PubMed ID: 38696651
    [Abstract] [Full Text] [Related]

  • 9.
    Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, Iacovazzo D, Korbonits M.
    ; 1993 Sep 12. PubMed ID: 29389097
    [Abstract] [Full Text] [Related]

  • 10. GPR101 drives growth hormone hypersecretion and gigantism in mice via constitutive activation of Gs and Gq/11.
    Abboud D, Daly AF, Dupuis N, Bahri MA, Inoue A, Chevigné A, Ectors F, Plenevaux A, Pirotte B, Beckers A, Hanson J.
    Nat Commun; 2020 Sep 21; 11(1):4752. PubMed ID: 32958754
    [Abstract] [Full Text] [Related]

  • 11. The X-linked acrogigantism-associated gene gpr101 is a regulator of early embryonic development and growth in zebrafish.
    Trivellin G, Tirosh A, Hernández-Ramírez LC, Gupta T, Tsai-Morris CH, Faucz FR, Burgess HA, Feldman B, Stratakis CA.
    Mol Cell Endocrinol; 2021 Jan 15; 520():111091. PubMed ID: 33248229
    [Abstract] [Full Text] [Related]

  • 12. GPR101: Modeling a constitutively active receptor linked to X-linked acrogigantism.
    Costanzi S, Stahr LG, Trivellin G, Stratakis CA.
    J Mol Graph Model; 2024 Mar 15; 127():108676. PubMed ID: 38006624
    [Abstract] [Full Text] [Related]

  • 13. GPR101 Mutations are not a Frequent Cause of Congenital Isolated Growth Hormone Deficiency.
    Castinetti F, Daly AF, Stratakis CA, Caberg JH, Castermans E, Trivellin G, Rostomyan L, Saveanu A, Jullien N, Reynaud R, Barlier A, Bours V, Brue T, Beckers A.
    Horm Metab Res; 2016 Jun 15; 48(6):389-93. PubMed ID: 26797872
    [Abstract] [Full Text] [Related]

  • 14. Mutations in GPR101 as a potential cause of X-linked acrogigantism and acromegaly.
    Hou ZS, Tao YX.
    Prog Mol Biol Transl Sci; 2019 Jun 15; 161():47-67. PubMed ID: 30711029
    [Abstract] [Full Text] [Related]

  • 15. X-LAG: How did they grow so tall?
    Beckers A, Rostomyan L, Potorac I, Beckers P, Daly AF.
    Ann Endocrinol (Paris); 2017 Jun 15; 78(2):131-136. PubMed ID: 28457479
    [Abstract] [Full Text] [Related]

  • 16. Aggressive tumor growth and clinical evolution in a patient with X-linked acro-gigantism syndrome.
    Naves LA, Daly AF, Dias LA, Yuan B, Zakir JC, Barra GB, Palmeira L, Villa C, Trivellin G, Júnior AJ, Neto FF, Liu P, Pellegata NS, Stratakis CA, Lupski JR, Beckers A.
    Endocrine; 2016 Feb 15; 51(2):236-44. PubMed ID: 26607152
    [Abstract] [Full Text] [Related]

  • 17. Congenital hypopituitarism in two brothers with a duplication of the 'acrogigantism gene' GPR101: clinical findings and review of the literature.
    Elizabeth MSM, Verkerk AJMH, Hokken-Koelega ACS, Verlouw JAM, Argente J, Pfaeffle R, Neggers SJCMM, Visser JA, de Graaff LCG.
    Pituitary; 2021 Apr 15; 24(2):229-241. PubMed ID: 33184694
    [Abstract] [Full Text] [Related]

  • 18. X-linked acrogigantism syndrome: clinical profile and therapeutic responses.
    Beckers A, Lodish MB, Trivellin G, Rostomyan L, Lee M, Faucz FR, Yuan B, Choong CS, Caberg JH, Verrua E, Naves LA, Cheetham TD, Young J, Lysy PA, Petrossians P, Cotterill A, Shah NS, Metzger D, Castermans E, Ambrosio MR, Villa C, Strebkova N, Mazerkina N, Gaillard S, Barra GB, Casulari LA, Neggers SJ, Salvatori R, Jaffrain-Rea ML, Zacharin M, Santamaria BL, Zacharieva S, Lim EM, Mantovani G, Zatelli MC, Collins MT, Bonneville JF, Quezado M, Chittiboina P, Oldfield EH, Bours V, Liu P, W de Herder W, Pellegata N, Lupski JR, Daly AF, Stratakis CA.
    Endocr Relat Cancer; 2015 Jun 15; 22(3):353-67. PubMed ID: 25712922
    [Abstract] [Full Text] [Related]

  • 19. Case report: Management of pediatric gigantism caused by the TADopathy, X-linked acrogigantism.
    Caruso M, Mazzatenta D, Asioli S, Costanza G, Trivellin G, Franke M, Abboud D, Hanson J, Raverot V, Pétrossians P, Beckers A, Cappa M, Daly AF.
    Front Endocrinol (Lausanne); 2024 Jun 15; 15():1345363. PubMed ID: 38481440
    [Abstract] [Full Text] [Related]

  • 20. Somatic GPR101 Duplication Causing X-Linked Acrogigantism (XLAG)-Diagnosis and Management.
    Rodd C, Millette M, Iacovazzo D, Stiles CE, Barry S, Evanson J, Albrecht S, Caswell R, Bunce B, Jose S, Trouillas J, Roncaroli F, Sampson J, Ellard S, Korbonits M.
    J Clin Endocrinol Metab; 2016 May 15; 101(5):1927-30. PubMed ID: 26982009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.